RBV Capital

General contacts
Investor type

VC

Founded

2014

AUM

-

Location

Zug, Zug, Switzerland

Investment Ticket

$1-5 m

Investment Stage

Series A Seed Series B

Region of investment

Europe
Investor profile last updated: 16 August, 2026

Profile

RBV Capital is a venture capital fund focused on life sciences, headquartered in an undisclosed location. Established in 2014, the firm specializes in investing in innovative biomedical projects. While the site provides little information on the team, RBV Capital is unique for its dedicated focus on the life sciences sector and its completed investment cycle indicating a shift towards divestment.

RBV Capital invests in the life sciences sector, specifically targeting innovative biomedical projects. The firm focuses on portfolio adjustments as it has completed its primary investment cycle. Information regarding specific check sizes and stages is not available, although their venture approach implies early to growth stages. No details are provided about their LPs or strategic partners.

The firm's portfolio includes a variety of innovative biomedical projects, though specific companies are not disclosed on their site. The emphasis on biomedical innovation suggests a proactive approach in contributing to health and science advancements.

Industry

Biotechnology Healthcare Services AI Medical Devices Pharmaceuticals MedTech Technology Life Sciences HealthTech

Contacts

Name
Title
Email
Social Networks
avatar
Robert Karl Chairman of the Board
Chairman of the Board
k•••@•••
LinkedIn
avatar
Igor Gonikhin Investment Director
Investment Director
g•••@•••
LinkedIn
Upgrade to see contacts
avatar
Z8sTdSgzQhxmqN5C Z8sTdSgzQhxmqN5C
Z8sTdSgzQhxmqN5C
[email protected]
linkedin twitter
avatar
Z8sTdSgzQhxmqN5C Z8sTdSgzQhxmqN5C
Z8sTdSgzQhxmqN5C
[email protected]
linkedin twitter
avatar
Z8sTdSgzQhxmqN5C Z8sTdSgzQhxmqN5C
Z8sTdSgzQhxmqN5C
[email protected]
linkedin twitter
Investment-team contacts for RBV Capital — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about RBV Capital

RBV Capital is a venture capital firm. It backs companies at Series A, Seed and Series B, writing tickets of $1-5 m.
RBV Capital is located in Zug, Zug, Switzerland.
RBV Capital was founded in 2014.
RBV Capital invests in companies and startups in Biotechnology, Healthcare Services, AI, Medical Devices, Pharmaceuticals, MedTech, Technology, Life Sciences, HealthTech.
RBV Capital invests in companies and startups in Europe.
RBV Capital invests in companies and startups at Series A, Seed, Series B.
RBV Capital usually invests $1-5 m on average.
RBV Capital can be reached through its website rbvcapital.com and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for RBV Capital — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query RBV Capital directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.